BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8099553)

  • 1. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
    Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
    Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
    Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on histamine H2-receptor antagonistic property of FRG-8813, a novel anti-ulcer drug].
    Inaba N; Shibata M; Onodera S; Tanaka M; Suzuki T; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):231-41. PubMed ID: 7774860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
    Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
    Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus in rats].
    Kagoshima M; Kodaira H; Shimada H
    Nihon Yakurigaku Zasshi; 1994 Nov; 104(5):379-89. PubMed ID: 7829023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
    Isobe Y; Nagai H; Muramatsu M; Aihara H; Otomo S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Nagaya H; Inatomi N; Satoh H
    Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of FRG-8813, a new type histamine H2-receptor antagonist, on various experimental gastric and duodenal lesions in rats].
    Yamaura T; Shibata M; Inaba N; Onodera S; Chida Y; Ohnishi H
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):401-10. PubMed ID: 1356897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
    Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
    Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice].
    Yamaura T; Shibata M; Chida Y; Inaba N; Onodera S; Ohnishi H
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):411-20. PubMed ID: 1356898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.
    Takagi T; Takeda M; Maeno H
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
    Okabe S; Nishida T; Igata H; Takagi K
    Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
    Takeda M; Takagi T; Maeno H
    Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
    Nakano M; Kitano S; Nanri M; Kiniwa M
    Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antisecretory potency and duration of action of the H2-receptor antagonists AH 22216, cimetidine, ranitidine and SK & F 93479 in the dog.
    Stables R; Daly MJ; Humphray JM
    Agents Actions; 1983 Apr; 13(2-3):166-9. PubMed ID: 6135321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of FRG-8813, a new histamine H2-receptor antagonist, on gastric mucus production in rats].
    Kagoshima M; Kodaira H; Tanaka M; Shimada H
    Nihon Yakurigaku Zasshi; 1995 Dec; 106(6):385-92. PubMed ID: 8582686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.